Vastned (LON:0ET5)
30.90
0.00 (0.00%)
At close: Dec 16, 2025
Vastned Revenue
Vastned had revenue of 16.85M EUR in the quarter ending June 30, 2025, with 242.77% growth. This brings the company's revenue in the last twelve months to 42.87M, up 121.64% year-over-year. In the year 2024, Vastned had annual revenue of 18.78M, down -1.03%.
Revenue (ttm)
42.87M EUR
Revenue Growth
+121.64%
P/S Ratio
11.98
Revenue / Employee
7.14M EUR
Employees
6
Market Cap
440.10M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18.78M | -196.00K | -1.03% |
| Dec 31, 2023 | 18.98M | 1.47M | 8.39% |
| Dec 31, 2022 | 17.51M | 717.00K | 4.27% |
| Dec 31, 2021 | 16.79M | -114.00K | -0.67% |
| Dec 31, 2020 | 16.91M | -2.36M | -12.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |